Calquence (acalabrutinib) plus bendamustine and rituximab reduced risk for disease progression or death by 27% compared with ...

In the POTOMAC study, one year of treatment with Imfinzi (durvalumab) plus standard-of-care BCG induction and maintenance ...

The American Association for Cancer Research has called on Congress "to summarily reject" the Trump administration's 2026 ...

PHILADELPHIA, PA — Context Therapeutics Inc. (Nasdaq: CNTX) has announced the appointment of Dr. Karen Smith, MD, PhD, MBA, ...

Despite a risk for severe side effects, pembrolizumab has a record of improving recurrence-free survival that makes it an appealing treatment for advanced melanoma.

Increased risk for attacks seen in women younger than 35 years, those with eosinophilia, and those with lower corticosteroid use.

Use of the investigational drug efruxifermin did not significantly reduce fibrosis in patients with compensated cirrhosis ...

Da and Uncle Andy dissect the week’s news with sketches, jokes and the occasional song. The Best of Nolan Stephen talks to Stephen Travers, who survived a UVF attack on the Miami Showband ...

AstraZeneca Pharma India Ltd., incorporated in the year 1979, is a Mid Cap company (having a market cap of Rs 20,457.50 Crore) operating in Pharmaceuticals sector. AstraZeneca Pharma India Ltd. key ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.